Advanced search
Publication Cover
Clinical Toxicology Volume 57, 2019 - Issue 1
Submit an article Journal homepage
498
Views
14
CrossRef citations to date
0
Altmetric
Clinical Research

Severe illness associated with reported use of synthetic cannabinoids: a public health investigation (Mississippi, 2015)

Amelia M. KasperEpidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, GA, USA; ;Division of Environmental Hazards and Health Effects, National Center for Environmental Health, Centers for Disease Control and Prevention, Atlanta, GA, USA; Correspondence[email protected]
ORCID Iconhttp://orcid.org/0000-0001-7332-1890View further author information
ORCID Icon,
Alison D. RidpathDivision of Environmental Hazards and Health Effects, National Center for Environmental Health, Centers for Disease Control and Prevention, Atlanta, GA, USA; View further author information
,
Roy R. GeronaDepartment of Laboratory Medicine, University of California San Francisco, San Francisco, CA, USA; View further author information
,
Robert CoxMississippi Poison Center, Jackson, MS, USA; View further author information
,
Robert GalliUniversity of Mississippi Medical Center, Jackson, MS, USA; View further author information
,
Patrick B. KyleUniversity of Mississippi Medical Center, Jackson, MS, USA; View further author information
,
Christina ParkerMississippi Poison Center, Jackson, MS, USA; View further author information
,
Justin K. ArnoldDivision of Environmental Hazards and Health Effects, National Center for Environmental Health, Centers for Disease Control and Prevention, Atlanta, GA, USA; ;Georgia Poison Center, Atlanta, GA, USA; View further author information
,
Kevin Chatham-StephensEpidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, GA, USA; ;Division of Environmental Hazards and Health Effects, National Center for Environmental Health, Centers for Disease Control and Prevention, Atlanta, GA, USA; View further author information
,
Melissa A. MorrisonCareer Epidemiology Field Officer Program, Office of Public Health Preparedness and Response, Centers for Disease Control and Prevention, Atlanta, GA, USA; ;Alabama Department of Public Health, Robertsdale, AL, USA; View further author information
,
Olaniyi OlayinkaEpidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, GA, USA; ;Division of Environmental Hazards and Health Effects, National Center for Environmental Health, Centers for Disease Control and Prevention, Atlanta, GA, USA; View further author information
,
Nykiconia PreacelyCareer Epidemiology Field Officer Program, Office of Public Health Preparedness and Response, Centers for Disease Control and Prevention, Atlanta, GA, USA; ;Mississippi State Department of Health, Jackson, MS, USAView further author information
,
Stephanie M. KieszakDivision of Environmental Hazards and Health Effects, National Center for Environmental Health, Centers for Disease Control and Prevention, Atlanta, GA, USA; View further author information
,
Colleen MartinDivision of Environmental Hazards and Health Effects, National Center for Environmental Health, Centers for Disease Control and Prevention, Atlanta, GA, USA; View further author information
,
Joshua G. SchierDivision of Environmental Hazards and Health Effects, National Center for Environmental Health, Centers for Disease Control and Prevention, Atlanta, GA, USA; View further author information
,
Amy WolkinDivision of Environmental Hazards and Health Effects, National Center for Environmental Health, Centers for Disease Control and Prevention, Atlanta, GA, USA; View further author information
,
Paul ByersMississippi State Department of Health, Jackson, MS, USAView further author information
&
Thomas DobbsMississippi State Department of Health, Jackson, MS, USAView further author information
 show all
Pages 10-18 | Received 26 Jan 2018, Accepted 01 Jun 2018, Published online: 10 Jul 2018

References

  • Ciolino LA. Quantitation of synthetic cannabinoids in plant materials using high performance liquid chromatography with UV detection (validated method). J Forensic Sci. 2015;60:1171–1181.
  • DrugFacts: high school and youth trends. National Institute on Drug Abuse website [cited 2016 Jul 20]. Available from: https://www.drugabuse.gov/publications/drugfacts/high-school-youth-trends.
  • Palamar JJ, Acosta P. Synthetic cannabinoid use in a nationally representative sample of US high school seniors. Drug Alcohol Depend. 2015;149:194–202.
  • Every-Palmer S. Synthetic cannabinoid JWH-018 and psychosis: an explorative study. Drug Alcohol Depend. 2011;117:152–157.
  • Centers for Disease Control and Prevention. Notes from the field: severe illness associated with synthetic cannabinoid use—Brunswick, Georgia, 2013. MMWR Morb Mortal Wkly Rep. 2013;62:939.
  • Centers for Disease Control and Prevention. Notes from the field: severe illness associated with reported use of synthetic marijuana — Colorado. MMWR Morb Mortal Wkly Rep. 2013;62:1016–1017.
  • Trecki J, Gerona RR, Schwartz MD. Synthetic cannabinoid-related illnesses and deaths. N Engl J Med. 2015;373:103–107.
  • Tyndall JA, Gerona R, De Portu G, et al. An outbreak of acute delirium from exposure to the synthetic cannabinoid AB-CHMINACA. Clin Toxicol (Phila). 2015;53:950–956.
  • Centers for Disease Control and Prevention. Acute kidney injury associated with synthetic cannabinoid use—multiple states, 2012. MMWR Morb Mortal Wkly Rep. 2013;62:93–98.
  • Louh IK, Freeman WD. A 'spicy' encephalopathy: synthetic cannabinoids as cause of encephalopathy and seizure. Crit Care. 2014;18:553.
  • Castaneto MS, Gorelick DA, Desrosiers NA, et al. Synthetic cannabinoids: epidemiology, pharmacodynamics, and clinical implications. Drug Alcohol Depend. 2014;144:12–41.
  • Lapoint J, James LP, Moran CL, et al. Severe toxicity following synthetic cannabinoid ingestion. Clin Toxicol. 2011;49:760–764.
  • Law R, Schier J, Martin C, et al. Increase in reported adverse health effects related to synthetic cannabinoid use—United States. MMWR Morb Mortal Wkly Rep. 2015;64:618–619.
  • Kasper AM, Ridpath AD, Arnold JK, et al. Severe illness associated with reported use of synthetic cannabinoids—Mississippi, April 2015. MMWR Morb Mortal Wkly Rep. 2015;64:1121–1122.
  • Synthetic Cannabinoids [cited 2018 May 26]. Available from: The American Association of Poison Control Centers website. http://www.aapcc.org/alerts/synthetic-cannabinoids.
  • Banister SD, Longworth M, Kevin R, et al. Pharmacology of Valinate and tert-Leucinate synthetic cannabinoids 5F-AMBICA, 5F-AMB, 5F-ADB, AMB-FUBINACA, MDMB-FUBINACA, MDMB-CHMICA, and their analogues. ACS Chem Neurosci. 2016;7:1241–1254.
  • Schedules of controlled substances: Temporary placement of the synthetic cannabinoid MAB-CHMINACA into Schedule I. Federal register 81 (24). Drug Enforcement Administration website [cited 2016 Jul 20]. Available from: http://www.deadiversion.usdoj.gov/fed_regs/rules/2016/fr0205_2.htm.
  • DHH Bans Another Synthetic Drug. Baton Rouge, LA WAFB 9 News website. October 29, 2014 [cited 2015 May 11]. Available from: http://www.wafb.com/story/27157019/dhh-bans-another-synthetic-drug.
  • Schedule I of controlled substances, MS Code § 41-29-113 (2013).
  • Hoyte CO, Jacob J, Monte AA, et al. A characterization of synthetic cannabinoid exposures reported to the National Poison Data System in 2010. Ann Emerg Med. 2012;60:435–438.
  • Wood KE. Exposure to bath salts and synthetic tetrahydrocannabinol from 2009 to 2012 in the United States. J Pediatr. 2013;163:213–216.
  • Adamowicz P, Gieroń J. Acute intoxication of four individuals following use of the synthetic cannabinoid MAB-CHMINACA. Clin Toxicol. 2016;54:650–654.
  • Katz KD, Leonetti AL, Bailey BC, et al. Case series of synthetic cannabinoid intoxication from one toxicology center. Westjem. 2016;17:290–294.
  • Dresen S, Ferreiros N, Putz M, et al. Monitoring of herbal mixtures potentially containing synthetic cannabinoids as psychoactive compounds. J Mass Spectrom. 2010;45:1186–1194.
  • Hoffman RS. Poison centers and poison epidemiology. In Hoffman R, Howland M, Lewin N, Nelson L, Goldfrank L, eds. Goldfrank's Toxicologic Emergencies. 10th ed. New York: McGraw Hill Education, 2015:1729–1730.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.